Included In This Lesson
Outline
What is the generic name?
TEBENTAFUSP
What is the Trade Name for TEBENTAFUSP?
KIMMTRAK
What are the Indications for TEBENTAFUSP?
- 1 INDICATIONS AND USAGE KIMMTRAK is indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma. KIMMTRAK is a bispecific gp100 peptide-HLA-directed CD3 T cell engager indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma ( 1 , 2.1 ).
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources